BioForce Nanosciences Holdings, Inc. BFNH
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -98.20K | -459.70K | -1.29M | -1.30M | -1.30M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -248.00K | 800.00 | 802.80K | 802.00K | 802.00K |
| Change in Net Operating Assets | 304.30K | 416.10K | 424.80K | 426.20K | 428.00K |
| Cash from Operations | -41.90K | -42.80K | -65.10K | -69.00K | -73.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 39.30K | 36.90K | 65.10K | 68.30K | 65.70K |
| Total Debt Repaid | 0.00 | -1.50K | -- | -- | -- |
| Issuance of Common Stock | 2.00K | -- | -- | 0.00 | 8.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 41.30K | 35.40K | 65.10K | 68.30K | 73.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -500.00 | -7.40K | -100.00 | -900.00 | 200.00 |